{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:53:28Z","timestamp":1778903608027,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.contraception.2012.08.042","type":"journal-article","created":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T15:31:10Z","timestamp":1349105470000},"page":"201-211","source":"Crossref","is-referenced-by-count":12,"title":["Ovarian activity in obese and nonobese women treated with three transdermal contraceptive patches delivering three different doses of ethinyl estradiol and levonorgestrel"],"prefix":"10.1016","volume":"87","author":[{"given":"Marie","family":"Foegh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David F.","family":"Archer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank Z.","family":"Stanczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arkady","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Daniel R.","family":"Mishell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2012.08.042_bb0005","first-page":"1","article-title":"Fertility, family planning, and reproductive health of U.S. women: data from the 2002 National Survey of Family Growth","volume":"23","author":"Chandra","year":"2005","journal-title":"Vital Health Stat"},{"key":"10.1016\/j.contraception.2012.08.042_bb0010","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.contraception.2004.03.009","article-title":"Contraceptive failure in the United States","volume":"70","author":"Trussell","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.042_bb0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.contraception.2007.09.013","article-title":"Estimates of contraceptive failure from the 2002 National Survey of Family Growth","volume":"77","author":"Kost","year":"2008","journal-title":"Contraception"},{"issue":"2 Pt 1","key":"10.1016\/j.contraception.2012.08.042_bb0020","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/AOG.0b013e3181e79440","article-title":"Ovarian suppression in normal-weight and obese women during oral contraceptive use: a randomized controlled trial","volume":"116","author":"Westhoff","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.042_bb0025","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0029-7844(02)01939-7","article-title":"Body weight and risk of oral contraceptive failure","volume":"99","author":"Holt","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.042_bb0030","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/01.AOG.0000149155.11912.52","article-title":"Body mass index, weight, and oral contraceptive failure risk","volume":"105","author":"Holt","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.042_bb0035","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10995-005-0015-5","article-title":"The association between body weight, unintended pregnancy resulting in a livebirth, and contraception at the time of conception","volume":"9","author":"Brunner Huber","year":"2005","journal-title":"Matern Child Health J"},{"key":"10.1016\/j.contraception.2012.08.042_bb0040","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.annepidem.2006.01.001","article-title":"Body mass index and risk for oral contraceptive failure: a case\u2013cohort study in South Carolina","volume":"16","author":"Brunner Huber","year":"2006","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.contraception.2012.08.042_bb0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/AOG.0b013e31820095a2","article-title":"Effectiveness of oral contraceptive pills in a large U.S. cohort comparing progestogen and regimen","volume":"117","author":"Dinger","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.042_bb0050","doi-asserted-by":"crossref","first-page":"263.e1","DOI":"10.1016\/j.ajog.2009.03.017","article-title":"Oral contraceptive effectiveness according to body mass index, weight, age, and other factors","volume":"201","author":"Dinger","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.042_bb0055","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.contraception.2008.12.013","article-title":"Association between efficacy and body weight or body mass index for two low-dose oral contraceptives","volume":"79","author":"Burkman","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.042_bb0060","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.contraception.2007.10.012","article-title":"The relationship between body mass index and unintended pregnancy: results from the 2002 National Survey of Family Growth","volume":"77","author":"Kaneshiro","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.042_bb0065","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/aje\/kwm221","article-title":"Obesity and oral contraceptive failure: findings from the 2002 National Survey of Family Growth","volume":"166","author":"Brunner Huber","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.contraception.2012.08.042_bb0070","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.contraception.2009.05.011","article-title":"Impact of body weight on observed pregnancy rates with a low-dose estrogen, 91-day extended regimen oral contraceptive","volume":"80","author":"Westhoff","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.042_bb0075","first-page":"CD008452","article-title":"Hormonal contraceptives for contraception in overweight or obese women","author":"Lopez","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2012.08.042_bb0080","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.contraception.2003.10.006","article-title":"The impact of improved compliance with a weekly contraceptive transdermal system (Ortho Evra) on contraceptive efficacy","volume":"69","author":"Archer","year":"2004","journal-title":"Contraception"},{"issue":"2 Suppl 2","key":"10.1016\/j.contraception.2012.08.042_bb0085","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S0015-0282(01)03263-0","article-title":"Assessment of compliance with a weekly contraceptive patch (Ortho Evra\/Evra) among North American women","volume":"77","author":"Archer","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2012.08.042_bb0090","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejogrb.2005.01.021","article-title":"Contraceptive efficacy, compliance and beyond: factors related to satisfaction with once-weekly transdermal compared with oral contraception","volume":"121","author":"Urdl","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2 Suppl 2","key":"10.1016\/j.contraception.2012.08.042_bb0095","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0015-0282(01)03275-7","article-title":"Contraceptive efficacy and cycle control with the Ortho Evra\/Evra transdermal system: the analysis of pooled data","volume":"77","author":"Zieman","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2012.08.042_bb0100","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1001\/jama.285.18.2347","article-title":"Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial","volume":"285","author":"Audet","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2012.08.042_bb0105","first-page":"231","article-title":"Pharmacokinetics, tolerability and cycle control of three transdermal contraceptive delivery systems containing different doses of ethinyl estradiol and levonorgestrel","volume":"6","author":"Stanczyk","year":"2011","journal-title":"Horm Mol Biol Clin Invest"},{"key":"10.1016\/j.contraception.2012.08.042_bb0110","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jchromb.2006.12.052","article-title":"A semi-automated 96-well plate method for the simultaneous determination of oral contraceptives concentrations in human plasma using ultra performance liquid chromatography coupled with tandem mass spectrometry","volume":"852","author":"Licea-Perez","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.contraception.2012.08.042_bb0115","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.clinbiochem.2005.10.012","article-title":"Evaluation of automated sex hormone binding globulin immunoassays","volume":"39","author":"Jin","year":"2006","journal-title":"Clin Biochem"},{"key":"10.1016\/j.contraception.2012.08.042_bb0120","first-page":"625","article-title":"Reference intervals for testosterone, androstenedione and SHBG levels in healthy females and males from birth until old age","volume":"51","author":"Elmlinger","year":"2005","journal-title":"Clin Lab"},{"key":"10.1016\/j.contraception.2012.08.042_bb0125","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/bio.1031","article-title":"Development of a high-throughput, indirect antibody immobilization format chemiluminescence enzyme immunoassay (CLEIA) for the determination of progesterone in human serum","volume":"23","author":"Ren","year":"2008","journal-title":"Luminescence"},{"key":"10.1016\/j.contraception.2012.08.042_bb0130","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S0002-9378(98)70292-3","article-title":"Ovarian activity in women taking an oral contraceptive containing 20 microg ethinyl estradiol and 150 microg desogestrel: effects of low estrogen doses during the hormone-free interval","volume":"179","author":"Killick","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.042_bb0135","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0015-0282(03)00556-9","article-title":"Ortho Evra\/Evra versus oral contraceptives: follicular development and ovulation in normal cycles and after an intentional dosing error","volume":"80","author":"Pierson","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2012.08.042_bb0140","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0002-9378(97)70520-9","article-title":"Single luteal phase serum progesterone assay as an indicator of ovulation","volume":"176","author":"Israel","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.042_bb0145","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0002-9378(99)70364-9","article-title":"The effects on ovarian activity of a monophasic oral contraceptive with 100 microg levonorgestrel and 20 microg ethinyl estradiol","volume":"181","author":"Coney","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.042_bb0150","unstructured":"Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER). December 15, 2004. Medical review of Application 21-583, DEPO-SUBQ PROVERA 104. Available at: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2004\/021583s000_MedR_P1.pdf. Accessed April 10, 2012."},{"key":"10.1016\/j.contraception.2012.08.042_bb0155","author":"Food and Drug Administration (FDA) Division of Reproductive and Urologic Drug Products"},{"key":"10.1016\/j.contraception.2012.08.042_bb0160","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0010-7824(99)00085-2","article-title":"Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): effects of body weight and injection sites on pharmacokinetics","volume":"60","author":"Rahimy","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.042_bb0165","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0010-7824(01)00226-8","article-title":"Levonorgestrel concentrations during 7 years of continuous use of Jadelle contraceptive implants","volume":"64","author":"Sivin","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.042_bb0170","doi-asserted-by":"crossref","first-page":"85S","DOI":"10.1016\/S0010-7824(98)00120-6","article-title":"Pharmacokinetics of Implanon: an integrated analysis","volume":"58","author":"Huber","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.042_bb0175","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.contraception.2009.04.011","article-title":"Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic\u2013pituitary\u2013ovarian activity","volume":"80","author":"Edelman","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.042_bb0180","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.contraception.2010.01.016","article-title":"Pharmacokinetics of a combined oral contraceptive in obese and normal-weight women","volume":"81","author":"Westhoff","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.042_bb0185","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0010-7824(93)90025-3","article-title":"Ultrasound evaluation of ovarian activity under oral contraceptives","volume":"47","author":"Hoogland","year":"1993","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.042_bb0190","first-page":"29","article-title":"Ovulation and follicular development associated with three low-dose oral contraceptives: a randomized controlled trial","volume":"83","author":"Grimes","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.042_bb0195","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0010-7824(03)00069-6","article-title":"Efficacy, safety and cycle control of five oral contraceptive regimens containing norgestimate and ethinyl estradiol","volume":"67","author":"LaGuardia","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.042_bb0200","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0010-7824(80)80003-5","article-title":"Escape ovulation in women due to missing of low dose combination oral contraceptive pills","volume":"22","author":"Chowdhury","year":"1980","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.042_bb0205","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1530\/acta.0.1020185","article-title":"Oestrogens induce an LH surge in a prepubertal patient with 45,X gonadal dysgenesis under prolonged pulsatile LRH administration","volume":"102","author":"de Waal HA","year":"1983","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.contraception.2012.08.042_bb0210","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0010-7824(01)00258-X","article-title":"Dose finding in a low-dose 21-day combined oral contraceptive containing gestodene","volume":"64","author":"Ludicke","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.042_bb0215","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.fertnstert.2009.06.057","article-title":"Suppression of ovarian function by a combined oral contraceptive containing 0.02 mg ethinyl estradiol and 2 mg chlormadinone acetate given in a 24\/4-day intake regimen over three cycles","volume":"94","author":"Spona","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2012.08.042_bb0220","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/13625189609150666","article-title":"The effects of a new low-dose combined oral contraceptive containing levonorgestrel on ovarian activity","volume":"1","author":"Teichmann","year":"1996","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2012.08.042_bb0225","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1210\/jcem-61-6-1158","article-title":"Effects of sex steroids on the positive estrogen feedback mechanism in intact women and castrate men","volume":"61","author":"Goh","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2012.08.042_bb0230","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1530\/acta.0.0710160","article-title":"Experimental studies on the endocrine regulations during the periovulatory phase of the human menstrual cycle. The effects of exogenous 17 \u03b2-oestradiol and progesterone on the release of pituitary luteinizing and follicle stimulating hormones","volume":"71","author":"Leyendecker","year":"1972","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.contraception.2012.08.042_bb0235","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1210\/jcem-57-4-797","article-title":"Induction of midcycle gonadotropin surge by ovarian steroids in women: a critical evaluation","volume":"57","author":"Liu","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2012.08.042_bb0240","first-page":"10","article-title":"Feedback effects of estradiol and progesterone upon gonadotropin and prolactin release","volume":"58","author":"March","year":"1981","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.042_bb0245","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1210\/jc.80.5.1541","article-title":"Midcycle levels of sex steroids are sufficient to recreate the follicle-stimulating hormone but not the luteinizing hormone midcycle surge: evidence for the contribution of other ovarian factors to the surge in normal women","volume":"80","author":"Taylor","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2012.08.042_bb0250","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1210\/jcem-41-6-1003","article-title":"Strength-duration characteristics of estrogen effects on gonadotropin response to gonadotropin-releasing hormone in women. I. Effects of varying duration of estradiol administration","volume":"41","author":"Keye","year":"1975","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2012.08.042_bb0255","first-page":"412","article-title":"Temporal relationship and reliability of the clinical, hormonal, and ultrasonographic indices of ovulation in infertile women","volume":"75","author":"Luciano","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.042_bb0260","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1469-0705.1992.02030197.x","article-title":"Intraovarian Doppler velocimetry in ovulatory, dysovulatory and anovulatory cycles","volume":"2","author":"Merce","year":"1992","journal-title":"Ultrasound Obstet Gynecol"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412008086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412008086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T06:08:04Z","timestamp":1562220484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782412008086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0010782412008086"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2012.08.042","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717961930.793465153","asserted-by":"object"}]},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}